Disease Overview：Atrophic gastritis（AG）
Atrophic gastritis is a chronic inflammatory condition characterized by progressive loss of gastric glandular cells, replacement with intestinal or fibrous tissue, and reduced gastric acid secretion (hypochlorhydria or achlorhydria). It is commonly associated with long-standing *Helicobacter pylori* infection, autoimmune mechanisms (e.g., anti-parietal cell antibodies), or environmental factors such as chronic bile reflux or dietary nitrosamines. Histologically, it features gastric mucosal thinning, decreased gland density, and metaplastic changes—including intestinal metaplasia—which confer an elevated risk for gastric dysplasia and adenocarcinoma. Diagnosis relies on upper gastrointestinal endoscopy with targeted biopsies, histopathological assessment (updated Sydney System classification), and adjunctive tests including serum pepsinogen I/II ratio, gastrin-17, and *H. pylori* serology or stool antigen testing. Management focuses on eradication of *H. pylori*, surveillance endoscopy for high-risk subtypes, nutritional support (e.g., vitamin B12 supplementation in pernicious anemia), and lifestyle modification.
China offers distinct advantages for atrophic gastritis management: leading gastroenterology centers—such as Peking Union Medical College Hospital and Zhongshan Hospital (Fudan University)—employ advanced endoscopic imaging (NBI, BLI, confocal laser endomicroscopy) for early detection of metaplasia and dysplasia. Multidisciplinary teams integrate pathology, molecular diagnostics, and precision surveillance protocols validated in large cohort studies. Treatment outcomes align with international benchmarks, with documented 5-year progression-free survival exceeding 92% in monitored cohorts. Costs remain significantly lower than in the US or Western Europe—endoscopic surveillance with biopsy and comprehensive serologic profiling typically costs 40–60% less, without compromising diagnostic accuracy or clinical rigor.
As a dedicated medical tourism agency, we facilitate seamless access to these high-standard services for international patients: coordinating appointments with certified specialists, verifying hospital accreditation (JCI or CNAS), providing itemized, transparent pricing in advance, and offering end-to-end support—from visa assistance and medical translation to post-procedure follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Atrophic Gastritis (Gastroenterology)
Non-Surgical / Conservative Management
*Target criteria:* Confirmed histopathology (biopsy-proven atrophy ± intestinal metaplasia), *H. pylori* positivity, or symptomatic chronic gastritis without dysplasia.
- •Eradication Therapy (*H. pylori* positive):
- *Itemized costs (USD):* - *H. pylori* urea breath test: $22–$35 - Gastric biopsy (endoscopy-guided, 2–4 specimens): $85–$120 - Histopathology report (including special stains for *H. pylori* and atrophy grading): $48–$72 - 14-day medication course (domestic generics): $18–$30
- •Mucosal Protection & Symptom Control (*H. pylori*-negative or post-eradication):
- Vitamin B12 supplementation (if serum B12 < 200 pg/mL): $8–$15/month - Follow-up endoscopy with targeted biopsy (yearly for moderate-severe atrophy/metaplasia): $195–$260 (includes sedation, pathology, reporting)
Surgical / Procedural Interventions
*Eligibility:* Confirmed high-grade dysplasia (HGD) or early gastric adenocarcinoma on biopsy — *not* routine atrophic gastritis management.
- •Endoscopic Submucosal Dissection (ESD):
- *Preoperative workup (mandatory):* - Enhanced abdominal CT: $110–$155 - ECG + chest X-ray + coagulation panel: $42–$65 - *Procedure cost (Grade 3A hospital, all-inclusive):* $2,400–$3,800
- •Laparoscopic Gastrectomy (partial/total):
- *Preoperative staging (EUS + PET-CT if indicated):* $320–$490 - *Surgery + 5-day inpatient stay (3A hospital):* $6,200–$9,500
Special / Complex Condition Management
- •Autoimmune Atrophic Gastritis (AAG) with pernicious anemia:
- Annual gastric surveillance endoscopy + chromoendoscopy: $260–$340
- •Atrophy with extensive intestinal metaplasia (OLGA/OLGIM Stage III–IV):
Quick Selection Guide
- •<45 years, *H. pylori*+, mild symptoms, budget <$100: Start with eradication therapy + 1 follow-up breath test ($65–$95 total)
- •55–75 years, OLGA Stage III, no dysplasia, comorbid diabetes/hypertension: Annual endoscopy + B12 monitoring ($300–$400/year)
- •Any age with biopsy-confirmed HGD: Proceed directly to ESD ($2,400–$3,800) — *delay increases cancer risk*
- •>75 years, frail, multiple comorbidities, HGD confirmed: Palliative PPI + B12 + symptom-focused care ($200–$350/year) — avoid invasive procedures unless life-threatening bleeding occurs
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Atrophic gastritis Medical Vacation Packages
Curated transparent all-inclusive packages combining Atrophic gastritis treatment with China top medical destinations:
